33% YoY growth masked by margin compression; FY27 guidance narrowed
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Narrowed prior 10-20% guidance to 10-15%; EBITDA margin 8.9% vs ~10% target; PAT down 9.3% QoQ despite YoY growth.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong 33.5% YoY revenue growth undermined by margin compression (8.9% EBITDA vs 10% guide) and guidance narrowing (10-20% → 10-15%). Raw material and OPEX headwinds offset volume gains. Long-term expansion plans (new capacity, geographic diversification) are credible but rely on cost normalization and demand sustenance.
₹325 Cr
Revenue · +33.5% YoY₹18 Cr
Reported PAT · +null% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Revenue growth 33.5% YoY driven by volume and pricing
METQ2 revenue ₹325 Cr vs Q1 ~₹339 Cr (₹661 H1 / 2), implying -4.1% QoQ decline; volume 15,656 MT vs prior year
EBITDA margins 8.9% in Q2; targeting ~10% for FY27
OVERSTATEDQ2 EBITDA 8.9% delivered vs prior FY26 baseline 12.6%; margin compression vs prior guide
Debtlessnecking will enable 70-75% utilization and higher volumes
Partial50K MT new capacity added; targeting 70-75% utilization 'basically this year' but earlier guidance deferred to FY28; unresolved timing
Exports 37% of revenue, strengthening geographic diversification
METExport revenue ₹244 Cr in H1, ~37% of ₹661 Cr H1 total; claim supported by numbers
Maintaining 10-15% FY27 growth target despite rising costs
OVERSTATEDPrior guidance 10-20%; narrowed to 10-15% and citing margin pressure from OPEX/raw material; credibility questioned
Earnings quality
What changed since the last call
FY27 revenue growth guidance narrowed
DowngradePrior guidance 10–20% (from Q1 FY27 call); now 10–15%. CFO states focus on 'absolute growth' vs margin improvement due to cost headwinds.
EBITDA margin target deferred
DowngradeGuided ~10% for FY27; Q2 delivered 8.9%. Management cites ongoing raw material and OPEX inflation (3–4 months additional pressure expected).
Capacity utilization milestone delayed
NeutralPrior guidance deferred 70–75% utilization to FY28; now stating 'basically' achievable this year with 50K MT new capacity, but no firm timeline given.
Export geography expanded
UpgradeNow exporting to 80+ countries (vs ~50 prior); SE Asia focus shifts from Korea-only to Thailand, Malaysia, China also. Export revenue ₹244 Cr (37% of H1).
The Q&A
Analysts pressed hard on margin compression (Yash Kabra: EBITDA declined sharply, why?). Management defended citing raw material and OPEX inflation, deferred optimization to H2. On capacity, Shubham Purohit challenged timing: when will 50K MT contribute volumes? Nikunj was vague ('next year, probably'). Analysts tested working capital: Vivek Jhala asked if WC availability was constraint; CFO said 'no issue right now.' Overall, pushback was moderate; management acknowledged challenges but lacked concrete near-term mitigation.
Geographic expansion and export — Reyna Patel, Shah Family Office
AnsweredGeographic diversification ongoing; added 80-plus countries, now exploring SE Asia (Thailand, Malaysia, China beyond Korea). Key contracts for Korean customers were fulfilling; LME registration enabled market access. Focus on stronger relationships with existing customers rather than purely new customers.
Domestic raw material sourcing — Reyna Patel, Shah Family Office
PartialCurrently 15% domestic, aiming 10% increase; auctions rising (prior 15%, now 10-27% domestic participation). Domestic sourcing more expensive due to competition from unorganized sector. Focus on participating in auctions for tower companies and domestic corporates; formalizing industry expected in next 3-4 years.
EBITDA margin and cost pressure — Yash Kabra, Nirmal Bang Securities
DodgedRaw material cycle impacts margins. Prior year 12% average EBITDA; Q2 at 8.9%. War-driven input cost inflation (fuel, OPEX) ongoing. 2 quarters affected by procurement cost headwinds. Management targeting margin maintenance at current levels; focusing on volume growth rather than absolute margin recovery.
Sales volume target and debtlessnecking impact — Shubham Purohit, SBJ Securities
PartialProbably next year for significant contribution. Debtlessnecking increased capacity; optimum utilization reachable with added capacity. Existing facility was brownfield; replacements of machinery sized up output. 10-15% growth achievable within current and new capacity.
New land acquisition and capex plans — Yash Kabra, Nirmal Bang Securities
DodgedLand allocated to company; official handover pending. Allotment letter received. Land is adjacent to existing facility; intended for future business growth. Concrete plans still being developed.
Customer concentration and repeat business — Nayan, Ertiga
AnsweredTop 7-10 customers with Ardee since 2021 (acquisition point). Approval and new customer onboarding takes 1–1.5 years. Repeat business strong for battery manufacturers and corporate customers. Focus on deepening existing relationships vs. pure new customer acquisition.
Working capital and procurement sourcing — Vivek Jhala, Jhala Family Office
AnsweredRaw material availability is main constraint, not working capital. No WC issue currently. Import and domestic sourcing both underway; focus on battery scrap sourcing from domestic and international sources. Volumes improving; margins expected to remain at current levels.
Lithium-ion battery recycling opportunity — Nirav Shah, GeoCo Holdings
PartialEvaluating lithium-ion but cautious. Copper and plastic recycling also being explored for diversification. ROI and capital requirements are key constraints. Government regulations and chemistry complexity are being monitored; likely a long-term product, not immediate.
Forex exposure and commodity pricing — Yash Kabra, Nirmal Bang Securities
AnsweredLME prices ranged USD 1,850–1,950 per tonne; pricing difficult to predict. Forex impact via import base and export base; net exposure 5–10% only (import and export hedges). Dollar-link on metal prices; most pricing in domestic market is local currency.
Lead recovery and cost drivers — Mandira A, Investco
AnsweredRecovery broadly ranges; value-add ~30%, pure lead ~70%. Premium for branded lead exists (some customers pay, some don't) depending on geography. Oxygen enrichment saves ~5% fuel cost. Specialized lead alloys offer higher margins and are focus area.
Volume guidance and Q1 vs Q2 trajectory — Ravi Mehta, OneUp
AnsweredQ2 last year 15K MT; Q2 this year 15.7K MT (flat). H1 FY26 30.7K MT; H1 FY27 33.3K MT (8.5% growth). Broadly flat volumes Q2 vs last year; second half expected to show improvement.
Guidance
FY27 revenue growth 10–15% (narrowed from prior 10–20%)
MediumVolume-driven growth expected; targeting 10–15% volume growth to achieve revenue target. Prior guidance 10–20% now narrowed due to cost headwinds and macro uncertainty.
EBITDA margin maintain ~10% for FY27 (vs 12.6% FY26)
LowQ2 delivered 8.9%; raw material and OPEX costs expected to persist 3–4 months. Focus shifted to volume growth vs. margin expansion. Management hedges on cost normalization.
Focusing on absolute growth; margins on volume basis expected to maintain current levels
LowPer CFO: cost headwinds constraining margin upside. Optimization and procurement improvements expected H2 FY27 onwards.
Debtlessnecking and capacity expansion (50K MT added) already completed; new land at Nadupeta in development phase
MediumNo specific capex amount for Nadupeta disclosed. Handover pending; concrete plans to be shared in few months. Implies FY27–FY28 capex continues.
Risks the call surfaced
Raw material cost volatility
HighRaw material (lead, battery scrap, fuel) costs have inflated due to geopolitical tensions and global supply chain disruptions. EBITDA margin compressed from 12.6% (FY26) to 8.9% (Q2 FY27). Management cites 3–4 months additional pressure expected.
Customer concentration
HighTop 7–10 battery manufacturers are dominant customers; ~50 total customers in portfolio. Loss of a large battery manufacturer would materially impact revenue. Long customer approval and onboarding cycle (1–1.5 years) limits ability to rapidly replace lost revenue.
Forex exposure and commodity pricing
MediumExport revenue at ₹244 Cr (37% of H1 revenue) exposes company to forex fluctuations. LME-linked lead pricing creates volatility. Hedging coverage only 5–10% (net exposure after import and export hedges). Lead prices ranged USD 1,850–1,950 per tonne in Q1–Q2; unpredictable and difficult to forecast.
Capacity utilization and capex execution
MediumDebtlessnecking (50K MT added capacity) is underway but contribution timeline vague ('probably next year'). New land at Nadupeta acquired but concrete plans still in development. Failure to ramp new capacity on schedule risks capacity underutilization and capex overruns.
Guidance credibility and near-term headwinds
MediumPrior guidance (10–20% growth, ~10% EBITDA margin) has been narrowed to 10–15% growth with 8.9% Q2 margin delivery. QoQ revenue decline (-4.1%) and PAT decline (-9.3%) in Q2 raise questions on H2 momentum. Cost headwinds expected to persist 3–4 months (through Dec 2026 roughly).
Management
Score 6/10. Defensive on margin compression; candid about cost headwinds and geopolitical impact. Vague on capex timelines (Nadupeta 'few months' away from plans). Transparent on customer concentration and working capital. NDA shields withheld some competitive details. Hit 33.5% YoY revenue growth (beats prior 10–20% lower end). But narrowed FY27 growth guidance to 10–15%, signaling mid-year reset due to cost and macro pressures. EBITDA 8.9% vs ~10% target is a miss. Debtlessnecking ramp timeline slipped to 'probably next year.'
1 · Q3–Q4 FY27
50K MT debtlessnecking ramp-up to drive capacity utilization and volume growth 10–15%
2 · H2 FY27
Raw material cost normalization; management expects margin improvement if inflation moderates
3 · FY28
New 6-acre land at Nadupeta (Andhra Pradesh) enables expansion; 70-75% optimal utilization achieved
Long-term expansion plans (new capacity, geographic diversification) are credible but rely on cost normalization and demand sustenance.
Ardee Indu stries Q2 FY27: PAT falls 38% YoY as margins compress despite 34% revenue growth
PAT -37.79% YoY · revenue +33.5% · margins compressing
₹324.79 Cr
+33.5% YoY
₹18.06 Cr
-37.79% YoY
5.54%
₹0.57
Ardee Industries' standalone revenue for Q2 FY27 (quarter ended September 30, 2026) came in at ₹324.79 Cr, up 33.5% year-on-year from ₹243.29 Cr but down 4.1% sequentially from ₹338.81 Cr. Standalone PAT fell 37.8% YoY to ₹18.06 Cr (from ₹29.03 Cr) and was down 9.3% QoQ (from ₹19.90 Cr), with basic EPS at ₹0.57 against ₹1.20 a year ago and ₹0.78 last quarter — the EPS decline is sharper than the profit decline because the fresh IPO issuance of 60.38 million shares (listed on NSE/BSE August 12, 2026) diluted the per-share base mid-quarter. There are no exceptional items on the face of the statement, so this is a genuine operating-margin story rather than a one-off.
Q2 FY-2027 vs prior quarters
No year-ago quarter on record — YoY cells may be blank.
The profit decline is almost entirely a margin story: operating margin (EBITDA/revenue) compressed to roughly 8.6% in Q2 from about 19.4% a year ago and 9.9% last quarter, while net margin fell to 5.56% from 11.93% YoY. The squeeze traces mainly to the cost-of-materials line, which rose to 81.4% of revenue from 78.0% a year ago, compounded by an inventory drawdown this quarter (adding ₹5.16 Cr to costs) versus an inventory build a year ago (which had reduced costs by ₹24.31 Cr) — roughly an 11-12 percentage-point swing on its own. Partly offsetting this, finance costs fell 66% YoY to ₹2.19 Cr (from ₹6.48 Cr) on debt paydown funded by IPO proceeds.
The stock went into the print at ₹45, down 6.7% over the past month of trading.
FY27 revenue growth 10-20% volume-driven; EBITDA margins ~10% (vs 12.6% FY26); optimum 70-75% capacity utilization deferred to FY28; ₹400+ Cr gross working capital requirement targeted.
— This quarter: met
Street comparison isn't meaningful here — Ardee has no active sell-side analyst coverage, so there is no consensus estimate to benchmark against. Against management's own guidance from the Q1 FY27 concall, revenue is running well ahead of plan: H1 FY27 revenue of ₹663.60 Cr is up 34.4% YoY, above the top end of the 10-20% volume-led growth management guided for the full year. Margins, however, are tracking the guided compression rather than beating it — H1 OPM of ~9.3% sits close to management's ~10% target (itself a step down from FY26's 12.6%), and Q2 OPM of 8.6% is a touch below even that lowered bar, with the 70-75% capacity-utilisation target still deferred to FY28 as flagged last quarter. The quarter's dominant corporate event was the IPO itself: Ardee raised net proceeds of ₹286.27 Cr (gross ₹319.99 Cr) via a fresh issue of 60.38 million shares plus an offer for sale of 19.98 million shares; ₹20 Cr has already gone to debt prepayment and ₹199.47 Cr of the ₹220 Cr earmarked for incremental working capital is utilised, while current borrowings fell to ₹34.82 Cr from ₹167.84 Cr at FY26-end. No separate management press release accompanied this filing beyond the standard board-outcome letter and notes to the financial statements.
W1
Operating margin trajectory toward management's ~10% FY27 EBITDA margin guidance (H1 at ~9.3%, Q2 at ~8.6%), with 70-75% capacity utilisation still deferred to FY28
W2
Deployment of the ₹66.98 Cr of still-unutilised net IPO proceeds (₹20.53 Cr working capital + ₹46.17 Cr general corporate, as of Sep 30, 2026)
W3
Whether revenue growth holds above the 10-20% FY27 guided band given this quarter's 4.1% QoQ moderation (H1 YoY growth at +34.4%)
₹325 Crore Quarter Masks a Margin Collapse
Revenue spiked 33.5% YoY to ₹325 Cr, but EBITDA margins compressed to 8.9% from 12.6%, profit fell 9.3% QoQ, and guidance was cut mid-year. The growth is real; the profitability gains are not.
₹18 Cr
Q2 FY27
8.9%
vs 12.6% FY26 · vs ~10% guided
+33.5% YoY
₹325 Cr Q2 | but -4.1% QoQ
10–15%
narrowed from 10–20%
Ardee's Q2 tells two contradictory stories. The headline reads bullish: revenue jumped 33.5% YoY, and the company has added 50,000 MT of new capacity and expanded exports to 80+ countries. But below the line, margins collapsed. EBITDA fell to 8.9% from 12.6% a year ago, profit dropped 9.3% quarter-on-quarter despite the YoY growth, and management cut its full-year guidance from 10–20% to 10–15% — a tacit admission mid-year that the quarter's cost pressures will not ease as hoped. The real story is margin compression, not revenue growth.
Where the profit went
Q2 net profit of ₹18 Cr (5.5% margin) landed cleanly. But the EBITDA shortfall is the problem. Management guided ~10% EBITDA margin for FY27 and delivered 8.9% — a 110-basis-point miss. The culprit is unambiguous: raw material (lead, battery scrap, imported inputs) and OPEX (fuel, wages, utilities) costs spiked due to global supply-chain disruption and the geopolitical environment. Management expects these headwinds to persist 3–4 months longer, implying pressure through at least November/December 2026.
Claims vs. what holds up
Revenue growth 33.5% YoY driven by volume and pricing
EBITDA margins 8.9% in Q2; maintaining ~10% for FY27
50K MT new capacity will enable 70–75% utilization this year
Exports at 37% of revenue; expanding to 80+ countries
Maintaining 10–15% FY27 growth target despite cost headwinds
Verdict on each: The revenue growth is real — H1 FY27 clocked ₹661 Cr vs ₹494 Cr H1 FY26, a 34% jump. But it masks a QoQ decline: Q2 revenue was -4.1% from Q1 (~₹339 Cr implied). Volume is flat YoY (15.7K MT vs 15.6K MT last year). So the YoY growth is driven by pricing and mix, not volume lift — yet the guidance was cut. EBITDA at 8.9% is overstated vs the ~10% target; management cites ongoing inflation and admits no near-term recovery. The 50K MT debtlessnecking and 70–75% utilization are credible long-term ambitions, but the timeline is vague: management said 'probably next year' when asked when it will contribute volumes — a red flag for capex execution risk. Exports are real (₹244 Cr in H1 = 37% of total) and geographic diversification is a genuine hedge. The FY27 guidance cut (10–20% → 10–15%) is an overstatement of confidence; it signals management expects macro headwinds to persist.
What changed on this call
Three downgrades and one upgrade. Management is telegraphing a year of margin pressure and deferred capacity utilization, while the export franchise is becoming genuinely global. The net message: long-term optionality is intact; near-term leverage is absent.
How the street is positioned
The market's verdict has been swift and unforgiving. The stock closed at ₹42.97 on 2026-11-16, down 37.22% from its all-time high of ₹68.44 — a severe drawdown. It is trading below its 20-day SMA (₹44.84), 50-day SMA (₹48.23), and the RSI sits at 38.1 (neutral-to-oversold territory). The tape is not yet capitulating — volume is increasing — but it is repricing the story as a 'low-margin grind' rather than a growth story.
Ownership data (Q2 FY27) shows FII at 0.67% and DII at 5.24% — shallow institutional ownership. Bulk deals in August tell an interesting story: large buys by NK Securities, Two Roads Trading, GRT Ventures, and Vinod Manjibhai Chauhan around ₹69–70 per share (mid-August highs), followed by promotional selling at ₹59 on Aug 14. That sequence — institutional accumulation into weakness, then promoter trimming — suggests insiders are managing the downside and pros are nibbling at the drawdown.
Bull-bear ledger
Bull: 33.5% revenue YoY growth is real; geographic diversification to 80+ countries hedges customer concentration
Bull: 50K MT new capacity and targeting 70–75% utilization offer long-term operating leverage
Bull: Stock down 37% from ATH; institutional accumulation at ₹69–70 suggests value re-entry
Bear: EBITDA margin at 8.9% vs ~10% guided; management admits 3–4 months more cost pressure ahead
Bear: QoQ profit down 9.3% despite YoY growth; volume is flat YoY (15.7K MT). Growth is not sustainable.
Bear: Capacity ramp timing is vague ('probably next year'); capex execution risk unresolved
Bear: Top 7–10 battery manufacturers are dominant customers; loss of one material supplier would crater volumes
Bear: Forex and commodity exposure (LME-linked lead pricing) only 5–10% hedged; volatility ahead
Risks, ranked by how much they should concern a holder
Margin recovery timeline keeps slipping
HighEBITDA is 8.9% vs 10% guided; management expects 3–4 months more cost pressure (through ~Nov/Dec 2026). If inflation persists beyond that, FY27 EBITDA could close at 8–9%, not 10%+. That would trigger another guidance cut and further selloff.
Customer concentration and loss of a top battery manufacturer
HighTop 7–10 battery manufacturers are ~70%+ of revenue. Onboarding a new customer takes 1–1.5 years. Loss of a Chloride or similar would crater volumes; FY27 growth target becomes unachievable.
Capacity ramp misses (50K MT debtlessnecking doesn't contribute as hoped)
HighNew capacity is the lever for 70–75% utilization and margin recovery. If capex execution slips or volumes don't materialize, management will cut guidance again in Q3/Q4 FY27.
Raw material cost inflation persists into 2027
MediumCurrently blaming Ukraine war, fuel costs, LME volatility (₹1,850–1,950/tonne). If geopolitical tension does not ease, EBITDA margin stays under 9% all through FY27–FY28, eroding investor patience.
Forex headwinds from LME lead prices or rupee weakness
MediumOnly 5–10% hedged. Export revenue (37% of sales) is exposed. A sharp ₹/$ move or lead price spike could swing Q3 earnings unpredictably.
The debate
What to watch next
1 · Q3 FY27 EBITDA margin recovery
Management expects cost inflation to ease in 3–4 months. If Q3 EBITDA margin rebounds to ~9.5–10%, the case re-establishes itself and the stock could recover 15–20% by Jan 2027. If it stays at 8–8.5%, another guidance cut is likely and the stock goes lower.
2 · Volume trajectory in H2 FY27
H1 volume was 33.3K MT (on track for ~10% growth). If H2 volume jumps to >17K MT per quarter (vs flat 15.7K MT Q2), management's 10–15% FY27 growth target is credible. If it stays flat, expect another guidance reset.
3 · Concrete capex plans for Nadupeta land (6-acre Andhra Pradesh facility)
Land was allotted but no capex plan shared yet. If management announces a capex budget and timeline for Nadupeta in Q3/Q4, it signals confidence in long-term demand. If it defers again, capex execution risk deepens.
The honest read
Ardee's Q2 is a case study in how headline growth can mask deteriorating fundamentals. Revenue up 33.5% sounds impressive. But margins are compressed, profit fell quarter-on-quarter, guidance was cut, and management admits 3–4 months of cost headwinds remain. This is not a step-change story; it is a steady, margin-pinched grind.
The bull case for FY28+ is intact: new capacity, geographic diversification, and industry tailwinds (EPR formalization, battery recycling growth) are real. But FY27 is a year of patience, not profits. The stock's 37% drawdown from its all-time high has repriced this accurately. A holder should tighten stops and wait for Q3 margin recovery; a buyer should sit out until November 2026 earnings give clarity on cost normalization. The number to track from here is EBITDA margin in Q3 — if it stays under 9%, the margin story is broken, not cyclical.
Rating: Hold / Downgrade to HOLD for growth-chasing buyers.